万维提示：
1、投稿方式：在线投稿。
2、刊内网址：
https://www.wjgnet.com/1948-0210/index.htm
更多网址如下。
3、投稿网址：https://www.f6publishing.com/
4、官网邮箱：dencaot@nus.edu.sg（主编）
choc.uci@gmail.com（主编）
5、出刊日期：月刊，每月26日出版。
2021年10月29日星期五
刊内网址【2021年08期信息】
INSTRUCTIONS TO AUTHORS
https://www.wjgnet.com/bpg/gerinfo/204
GUIDELINES FOR ETHICS DOCUMENTS
https://www.wjgnet.com/bpg/GerInfo/287
GUIDELINES FOR NON-NATIVE SPEAKERS OF ENGLISH
https://www.wjgnet.com/bpg/gerinfo/240
PUBLICATION ETHICS
https://www.wjgnet.com/bpg/GerInfo/288
PUBLICATION MISCONDUCT
https://www.wjgnet.com/bpg/gerinfo/208
EDITORIAL BOARD MEMBERS
https://www.wjgnet.com/1948-0210/editorialboard.htm
ARTICLE PROCESSING CHARGE
https://www.wjgnet.com/bpg/gerinfo/242
STEPS FOR SUBMITTING MANUSCRIPTS
https://www.wjgnet.com/bpg/GerInfo/239
投稿须知【官网信息】
背景
World Journal of Stem Cells (WJSC, World J Stem Cells) is a high-quality, online, open-access, single-blind peer-reviewed journal published by the Baishideng Publishing Group (BPG). WJSC accepts both solicited and unsolicited manuscripts. Articles published in WJSC are high-quality, basic and clinical, influential research articles by established academic authors as well as new researchers. The paramount objective of WJSC is to showcase and promote distinguished research in the field of stem cells, to help advance development of this field. The types of articles published in WJSC include Editorial, Opinion Review, Frontier, Review, Minireview, Basic Study, Clinical Research, Systematic Review, Meta-analysis, Evidence-based Medicine, Field of Vision, Clinical Guidelines, Letter to the Editor, and Case Report.
目的
The primary aim of WJSC is to provide scholars and readers from various fields of stem cells with a platform to publish high-quality research articles and communicate their research findings online. In order to ensure the quality, timeliness, fairness, and transparency of publication, WJSC has implemented a variety of measures as follows:
First, authors must prepare their articles according to the appropriate international publication recommendations, including the STROBE Statement, CONSORT 2010 Statement, PRISMA 2009 Checklist, and CARE Checklist – 2016: Information for writing a case report.
Second, articles published in WJSC must undergo rigorous cross-international peer review. WJSC peer reviewers come from different countries, chosen independently by artificial intelligence technique or our editorial office, and not by the authors, to ensure fairness and integrity of the peer review.
Third, designation of co-first authors and/or co-corresponding authors is not permitted.
Fourth, WJSC accepts a manuscript for publication based on its novelty, innovativeness, data accuracy, image reliability, clear language expression, and ethical requirements.
Of note, peer reviewers are advised to complete their peer review within 7 days, providing a comprehensive evaluation of the scientific and linguistic quality of the manuscript.
Fifth, BPG adopts a 7-day publishing management policy. This means that each step of the publishing process, including manuscript preview, peer review, manuscript revision by authors, final acceptance, language editing, and production, and release, must be completed within 7 days.
Finally, the peer review report, author’s response to the peer review report, biostatistics review certificate, copyright license agreement, institutional ethics committee approval document, informed consent document(s), conflict-of-interest statement, CrossCheck detection report, authors’ personal ORCID numbers, funding information, language editing certificate, and other relevant documents will be published online along with the article to allow for an open and transparent publishing process.
范围
WJSC mainly publishes articles reporting research results obtained in the field of stem cell biology and regenerative medicine, related to the wide range of stem cells including embryonic stem cells, germline stem cells, tissue-specific stem cells, adult stem cells, mesenchymal stromal cells, induced pluripotent stem cells, embryoid bodies, embryonal carcinoma stem cells, hemangioblasts, hematopoietic stem cells, lymphoid progenitor cells, myeloid progenitor cells, myoblasts (cardiac, skeletal, and smooth muscle), neoplastic stem cells, neural stem cells, other pluripotent stem cells, side-population cells, and totipotent stem cells.
INSTRUCTIONS TO AUTHORS
投稿须知：
https://www.wjgnet.com/bpg/gerinfo/204
